Lipoic acid in multiple sclerosis: a pilot study. - Wikidata - awgldk - TriplyDB

Lipoic acid in multiple sclerosis: a pilot study.

Lipoic acid in multiple sclerosis: a pilot study.

http://www.wikidata.org/entity/Q46407394

about

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development Dietary interventions for multiple sclerosis Dietary interventions for multiple sclerosis Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases Dietary lipoic acid-dependent changes in the activity and mRNA levels of hepatic lipogenic enzymes in rats Complementary and alternative medicine for the treatment of multiple sclerosis Role of the immune system in hypertension: modulation by dietary antioxidants.Recent developments in multiple sclerosis therapeutics Emerging therapies in multiple sclerosis.Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.Lipoic acid in secondary progressive MS: A randomized controlled pilot trial.Questions asked and answered in pilot and feasibility randomized controlled trials.The influence of nutritional factors on the prognosis of multiple sclerosis.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injury.Quantum-chemical investigation of the structure and the antioxidant properties of α-lipoic acid and its metabolites Analysis of Reaction between α-Lipoic Acid and 2-Chloro-1-methylquinolinium Tetrafluoroborate Used as a Precolumn Derivatization Technique in Chromatographic Determination of α-Lipoic Acid.Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.Examining the evidence: complementary adjunctive therapies for multiple sclerosis.Antioxidant therapy in multiple sclerosis.Alpha-lipoic acid supplementation and diabetes Characterization of genome-wide transcriptional changes in liver and adipose tissues of ZDF (fa/fa) rats fed R-α-lipoic acid by next-generation sequencing.α-Lipoic acid as a triglyceride-lowering nutraceutical.Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage.Tolerability in the elderly population of high-dose alpha lipoic acid: a potential antioxidant therapy for the eye.Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells.Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial.Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial.Lipoic acid induces p53-independent cell death in colorectal cancer cells and potentiates the cytotoxicity of 5-fluorouracil.Anodic Oxidation of α‐Lipoic Acid at a Glassy Carbon Electrode and Its Determination in Dietary Supplements

P2860

Q22241837-8B52FD8F-2D2C-4DCE-84F2-1011D6594073 Q24202428-DC705B97-EF2C-46EA-856F-A32FDA58586B Q24246218-21B58E0F-F5AD-45C9-AA4E-BF40D5441EB9 Q24658099-7C1D0C5A-D245-45B8-95EB-F67A22931064 Q28068709-0AC8DC9A-CED3-4E14-9309-9FF662B79683 Q28069705-11CFE664-8510-4158-B65C-4FBAD7074024 Q28569638-C65731E0-0CED-4C35-800A-5DC0C96755A7 Q29031018-8FD89360-7657-4CBB-875F-FAA66EAEF524 Q30424339-4E0C951C-8B0A-4DBA-99A6-FF92D037AC73 Q30962193-01872E4D-6776-411A-A03A-497BDE451C27 Q31015100-90B5DC17-1B91-4EE8-98E4-4F6272F810EF Q33712137-F6F54DB5-7657-4A4E-BABC-15C4B0461C6E Q33848866-D477FD37-F113-48FB-9DAC-FB623250CA9A Q33994043-8F331B16-CAC6-496C-A39C-31E38FCE1DE9 Q34643392-8F46E831-9B63-4123-AE0A-870B414D98F2 Q34685307-622CC9A8-9844-4A99-AB3A-906C457F91E6 Q34730353-5C84A398-2990-49D6-9E58-4C9DD2D95988 Q36055890-90D52068-B8B2-4FE8-BE8A-1D604C1E57D6 Q36173351-BEDC3953-72E1-4A20-B1FB-ECBB8FB31F98 Q36373827-6DACB7A4-E0A4-439D-9ADE-6A24AF2FEFD1 Q36484443-0E1BC7C5-0913-4E50-B325-A5DC08E55E0A Q37180260-A0D7EF1C-FA95-4708-9013-90B32933DC01 Q37217845-BF61EFBB-7B54-4348-ACDB-95CC9F384FCD Q37258404-023864A5-4CFD-46BB-B263-F56BCD58DC4F Q37329377-B9BBA539-D67F-42F6-9D55-6C6A4C562AD8 Q38484879-2A34F47A-3B4B-4C1A-B4D1-EEACD77BECD8 Q38559352-38BA6F55-F2F4-4469-8E95-8342276EE484 Q38569263-D7EABDB1-F57A-461B-86BE-6680AED7A5D3 Q38837294-9C37841D-509E-4A11-BD44-755C97AF49B7 Q38854377-0688B58D-7043-44FD-8CAC-5108EDEE8A3C Q38978374-A0C34AC2-AF04-422A-97CD-FFF6018C9E8D Q41974481-B13A30C6-11DC-424F-A7D6-560EC2FC18A7 Q43067486-2B9A400A-2F7D-47C7-8654-65898A766B74 Q46252229-4A120D41-C980-405B-91D5-1F43F668D57D Q47578122-95C7A576-5E56-400F-AD57-513C47C8428C Q50144469-C4D2AE9F-A9A1-4807-A30E-7D9D676A7876 Q51343458-C92F8F98-C104-4F3D-B323-EC654A839677 Q52981183-FE21D6DA-CB37-4ADF-B0C0-3F5729D31E6B Q58302908-34E5306B-16E2-49BF-A34F-09E19A1459EC

P2860

Lipoic acid in multiple sclerosis: a pilot study.

http://www.wikidata.org/entity/Q46407394

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Lipoic acid in multiple sclerosis: a pilot study.

@en

Lipoic acid in multiple sclerosis: a pilot study.

@nl

type

label

Lipoic acid in multiple sclerosis: a pilot study.

@en

Lipoic acid in multiple sclerosis: a pilot study.

@nl

prefLabel

Lipoic acid in multiple sclerosis: a pilot study.

@en

Lipoic acid in multiple sclerosis: a pilot study.

@nl

P1433

Q46407394-627BC6E6-AF7B-465F-8EDA-3C368979F98B

P1476

Q46407394-0FF639BE-4FF1-464B-9678-58DB7077A823

P2093

Q46407394-4D809767-C833-463A-B6B0-708AA2AB3B8B

Q46407394-5451BF53-5C36-42ED-AB8D-4C855830ADDB

Q46407394-548223BB-42D3-4A57-8DDD-77EDE4959355

Q46407394-9D676894-EC52-42BB-AAEB-70D65456E478

Q46407394-A826A607-3DE0-4BD5-9311-93AE9D0E3E0A

Q46407394-AD8AC53C-4044-4E8F-9EBB-640257F48A0D

Q46407394-AF5AD48C-0143-441E-B577-CF9F437DF37E

Q46407394-D4AC9C25-A19B-4153-9F5E-10C17C488B78

Q46407394-F3EA005E-654B-47B0-9592-8DC2A309D3D1

P2860

Q46407394-05DD97C0-3290-4A42-8845-CE81E1F23707

Q46407394-1790F588-DA25-4628-A670-CD23875572EB

Q46407394-1915D1BC-808E-4D13-B304-64EFF7E29AE8

Q46407394-1B73C6FF-AF8C-4D56-904D-C9999B908871

Q46407394-29E45F8E-C9C5-4440-8E1B-ACDD16CEF05E

Q46407394-4263C17D-70A3-43C2-9848-B7DBC586B106

Q46407394-4E78AEC0-1C5C-4DD9-A592-CDB8CF9B55E9

Q46407394-57582F5F-67AA-4359-8969-F4AC75490D7F

Q46407394-5A19540C-9C33-4B45-83A4-0A3D66C2E116

Q46407394-5A7194DD-BD77-4DA7-A754-497AA553E4DD

P304

Q46407394-9E6EBE13-ECF7-4347-90E3-B90489AFBCA5

P31

Q46407394-5637C4B8-B6C4-4ACB-995D-9918E9EA1E50

P356

Q46407394-145AE22C-B6C4-434C-8547-743D1A69AAA4

P433

Q46407394-27505EC3-F2E8-45E4-87DD-3566D62B0A04

P478

Q46407394-6077CD17-2BAC-48AD-AC7A-078B00389BFD

P577

Q46407394-381CBC15-BE9B-4258-BF59-863699B94E78

P5875

Q46407394-E99BA9DF-07F4-46B3-8E65-D466FADF7DC4

P698

Q46407394-A2E23902-8D48-4EA0-B873-DB9987BE5DF8

P921

Q46407394-C8BA5B8F-AD2A-499F-9D0B-76323CB3C9F3

P356

1352458505MS1143OA

P1433

Multiple Sclerosis Journal

P1476

Lipoic acid in multiple sclerosis: a pilot study.

@en

P2093

C Morris

http://www.w3.org/2001/XMLSchema#string

D Bourdette

http://www.w3.org/2001/XMLSchema#string

G Marracci

http://www.w3.org/2001/XMLSchema#string

J Lovera

http://www.w3.org/2001/XMLSchema#string

K Bogardus

http://www.w3.org/2001/XMLSchema#string

L Shinto

http://www.w3.org/2001/XMLSchema#string

V Yadav

http://www.w3.org/2001/XMLSchema#string

W Marquardt

http://www.w3.org/2001/XMLSchema#string

W Woodward

http://www.w3.org/2001/XMLSchema#string

P2860

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Multiple sclerosis

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

Immunopathogenesis of multiple sclerosis: the role of T cells.

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.

The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system.

Cell migration in the immune system: the evolving inter-related roles of adhesion molecules and proteinases.

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis.

Alpha-lipoic acid modulates NF-kappaB activity in human monocytic cells by direct interaction with DNA.

P304

159-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1191/1352458505MS1143OA

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7942307

http://www.w3.org/2001/XMLSchema#string

P698

15794388

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis